| Molecular requirements for epithelial–mesenchymal transition during tumor progression MA Huber, N Kraut, H Beug Current opinion in cell biology 17 (5), 548-558, 2005 | 2340 | 2005 |
| NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression MA Huber, N Azoitei, B Baumann, S Grünert, A Sommer, H Pehamberger, ... The Journal of clinical investigation 114 (4), 569-581, 2004 | 1288 | 2004 |
| BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo M Steegmaier, M Hoffmann, A Baum, P Lénárt, M Petronczki, M Krššák, ... Current biology 17 (4), 316-322, 2007 | 932 | 2007 |
| The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1 P Lénárt, M Petronczki, M Steegmaier, B Di Fiore, JJ Lipp, M Hoffmann, ... Current biology 17 (4), 304-315, 2007 | 776 | 2007 |
| A highly selective telomerase inhibitor limiting human cancer cell proliferation K Damm, U Hemmann, P Garin-Chesa, N Hauel, I Kauffmann, H Priepke, ... The EMBO journal 20 (24), 6958-6968, 2001 | 542 | 2001 |
| Transcriptional plasticity promotes primary and acquired resistance to BET inhibition P Rathert, M Roth, T Neumann, F Muerdter, JS Roe, M Muhar, S Deswal, ... Nature 525 (7570), 543-547, 2015 | 490 | 2015 |
| Autocrine PDGFR signaling promotes mammary cancer metastasis M Jechlinger, A Sommer, R Moriggl, P Seither, N Kraut, P Capodiecci, ... The Journal of clinical investigation 116 (6), 1561-1570, 2006 | 464 | 2006 |
| Expression profiling of epithelial plasticity in tumor progression M Jechlinger, S Grunert, IH Tamir, E Janda, S Lüdemann, T Waerner, ... Oncogene 22 (46), 7155-7169, 2003 | 403 | 2003 |
| Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle M Petronczki, M Glotzer, N Kraut, JM Peters Developmental cell 12 (5), 713-725, 2007 | 354 | 2007 |
| Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status C Haslinger, N Schweifer, S Stilgenbauer, H Dohner, P Lichter, N Kraut, ... Journal of Clinical Oncology 22 (19), 3937-3949, 2004 | 305 | 2004 |
| BI-3406, a potent and selective SOS1–KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition MH Hofmann, M Gmachl, J Ramharter, F Savarese, D Gerlach, ... Cancer Discovery 11 (1), 142-157, 2021 | 281 | 2021 |
| Mig6 is a negative regulator of EGF receptor–mediated skin morphogenesis and tumor formation I Ferby, M Reschke, O Kudlacek, P Knyazev, G Pantè, K Amann, ... Nature medicine 12 (5), 568-573, 2006 | 280 | 2006 |
| Mig6 is a negative regulator of EGF receptor–mediated skin morphogenesis and tumor formation I Ferby, M Reschke, O Kudlacek, P Knyazev, G Pantè, K Amann, ... Nature medicine 12 (5), 568-573, 2006 | 275 | 2006 |
| Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin H Dolznig, N Schweifer, C Puri, N Kraut, WJ Rettig, D Kerjaschki, ... Cancer immunity 5 (1), 2005 | 206 | 2005 |
| Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors MA Huber, RD Schubert, RU Peter, N Kraut, JE Park, WJ Rettig, ... Journal of investigative Dermatology 120 (2), 182-188, 2003 | 200 | 2003 |
| I-mf, a novel myogenic repressor, interacts with members of the MyoD family CMA Chen, N Kraut, M Groudine, H Weintraub Cell 86 (5), 731-741, 1996 | 200 | 1996 |
| DNA binding by c‐Ets‐1, but not v‐Ets, is repressed by an intramolecular mechanism. F Lim, N Kraut, J Framptom, T Graf The EMBO journal 11 (2), 643-652, 1992 | 161 | 1992 |
| Chemically induced degradation of the oncogenic transcription factor BCL6 N Kerres, S Steurer, S Schlager, G Bader, H Berger, M Caligiuri, C Dank, ... Cell reports 20 (12), 2860-2875, 2017 | 157 | 2017 |
| Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition F Gillardon, W Rist, L Kussmaul, J Vogel, M Berg, K Danzer, N Kraut, ... Proteomics 7 (4), 605-616, 2007 | 155 | 2007 |
| Requirement of the mouse I‐mfa gene for placental development and skeletal patterning N Kraut, L Snider, CMA Chen, SJ Tapscott, M Groudine The EMBO Journal, 1998 | 149 | 1998 |
